Association of antieosinophil therapy with decreased body mass index in patients with severe asthma: A preliminary retrospective analysis

Ann Allergy Asthma Immunol. 2019 Jun;122(6):649-650. doi: 10.1016/j.anai.2019.03.031. Epub 2019 Apr 4.

Authors

Merin Kuruvilla¹, Meera Patrawala², Joshua M Levy³, Jennifer Shih², Frances E Lee²

Affiliations

¹ Division of Pulmonary, Allergy, and Critical Care, Emory University School of Medicine, Atlanta, Georgia. Electronic address: merin.ek1@gmail.com.
² Division of Pulmonary, Allergy, and Critical Care, Emory University School of Medicine, Atlanta, Georgia.
³ Department of Otolaryngology-Head and Neck Surgery, Emory University School of Medicine, Atlanta, Georgia.

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Anti-Asthmatic Agents / therapeutic use*
Antibodies, Monoclonal, Humanized / therapeutic use*
Asthma / drug therapy*
Asthma / epidemiology
Body Mass Index
Cohort Studies
Disease Progression
Eosinophils / immunology*
Female
Humans
Interleukin-5 / antagonists & inhibitors
Interleukin-5 / immunology
Male
Middle Aged
Obesity / drug therapy*
Obesity / epidemiology
Retrospective Studies
Treatment Outcome
United States / epidemiology

Substances

Anti-Asthmatic Agents
Antibodies, Monoclonal, Humanized
Interleukin-5
reslizumab
benralizumab
mepolizumab

Grants and funding